Founder And Managing Partner
Current
Douglas Toal, Phd., D(Abmm), Llc
Provides consultation and direction to commercial clinical laboratory and biotech operations. Examines current processes and designs changes to ensure elimination of wasteful practices. Formulates and communicates business strategies in high tech medical diagnostic industries. Provides guidance in analytical and clinical validation of diagnostics tests.• Director of a CAP-accredited clinical laboratory performing clinical metabolomics for the detection of inborn errors of metabolism (Metabolon, Inc, Durham, NC). Works closely with key personnel to execute on new test development strategy.• Provides consultation to a biopharma firm in the development of a complex RNA signature to predict response to targeted oncology therapies. Develops product requirement documents, assay validation protocols and assesses RNA expression technologies. • Provides clinical consultative services to a biotechnology firm with innovative and first-of-kind diagnostics test for the diagnosis of Alzheimer’s Disease (SynapsDX, Inc, Rockville, MD). Acting Clinical Director, ensures implementation of quality management systems and established CLIA licensure for the operation. • Provides quality and regulatory guidance to a biotechnology firm (Accelevir Diagnostics, Baltimore, MD) focused on the molecular detection of low copy HIV in patients. • Provides Clinical Director oversight to clinical laboratories performing PCR testing for SARS-CoV-2. Works with management and staff to implement best practices and ensures compliance with regulatory authorities.• ABMM board certified Clinical Director providing support to a biotechnology Firm (OpGen, Inc) focused on the molecular detection of hospital-acquired infections using proprietary and first-in-class Microfluidics technology. Released patient reports and consulted with ordering physicians, collaborated with leading scientists to effect technology transfers. Promoted adoption of technology to Key Opinion Leaders.